Kainomyx Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $15.5M

  • Investors
  • 4

Kainomyx General Information

Description

Developer of therapeutic drugs designed to assist in the treatment of tropical and parasitic diseases. The company's platform combines parasite biology with biochemical and biophysical approaches for the development of specific drugs against pivotal target components of the parasites, enabling doctors to help patients treat malaria, leishmaniasis and other parasitic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 319 North Bernardo Avenue
  • Mountain View, CA 94043
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 319 North Bernardo Avenue
  • Mountain View, CA 94043
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kainomyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 26-Oct-2021 $15.5M Completed Generating Revenue
1. Grant 22-Sep-2021 Completed Generating Revenue
To view Kainomyx’s complete valuation and funding history, request access »

Kainomyx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Kainomyx’s complete cap table history, request access »

Kainomyx Patents

Kainomyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198777-A1 Myosin modulators and methods of their use Pending 20-Mar-2025

Kainomyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kainomyx Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Good Ventures Limited Partner Minority
Open Philanthropy Project Not-For-Profit Venture Capital Minority
Angel (individual) Minority
Gates Foundation Not-For-Profit Venture Capital
To view Kainomyx’s complete investors history, request access »

Kainomyx FAQs

  • When was Kainomyx founded?

    Kainomyx was founded in 2019.

  • Where is Kainomyx headquartered?

    Kainomyx is headquartered in Mountain View, CA.

  • What is the size of Kainomyx?

    Kainomyx has 7 total employees.

  • What industry is Kainomyx in?

    Kainomyx’s primary industry is Drug Discovery.

  • Is Kainomyx a private or public company?

    Kainomyx is a Private company.

  • What is the current valuation of Kainomyx?

    The current valuation of Kainomyx is .

  • What is Kainomyx’s current revenue?

    The current revenue for Kainomyx is .

  • How much funding has Kainomyx raised over time?

    Kainomyx has raised $15.5M.

  • Who are Kainomyx’s investors?

    Good Ventures, Open Philanthropy Project, , and Gates Foundation have invested in Kainomyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process